AMRN
HealthcareAmarin Corporation plc
$13.50
$-0.22 (-1.60%)
Jan 5, 2026
Price History (1Y)
Analysis
Amarin Corporation plc is a healthcare company operating in the Drug Manufacturers - General industry. With a market capitalization of $280.70M, it falls within the general category of drug manufacturers. Amarin has approximately 275 employees. The company's financial health is marked by negative profitability metrics, with an operating margin of -3.4% and a profit margin of -38.0%. Its return on equity (ROE) stands at -17.4%, while its return on assets (ROA) is -2.5%. Amarin has a relatively low debt-to-equity ratio of 1.97, but its current ratio of 3.45 indicates that it can cover short-term obligations. Amarin's valuation context is characterized by a forward P/E ratio of 22.88 and revenue growth of 17.4% year-over-year (YoY). The company has significant cash reserves of $286.59M, which far exceed its debt of $9.03M.
This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.
About Amarin Corporation plc
Amarin Corporation plc, a pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and internationally. The company offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. It sells its products principally through wholesalers, selected regional wholesalers, and specialty pharmacy providers. The company has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, EPA. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.
Visit website →Key Statistics
- Market Cap
- $280.70M
- P/E Ratio
- N/A
- 52-Week High
- $20.90
- 52-Week Low
- $7.00
- Avg Volume
- 109.54K
- Beta
- 0.73
Company Info
- Industry
- Drug Manufacturers - General
- Exchange
- NCM
- Country
- Ireland
- Employees
- 275